BYT BANGYTONG STYE EYE RELIEF SERUM ((hippophae rhamnoides seed oil , calendula officinalis flower , persea gratissim) by Shenzhen Jindali Technology Co., Ltd: new human otc drug listing
BYT BANGYTONG STYE EYE RELIEF SERUM: new human otc drug listing. Dated 14 days ago, it is in the active follow-up window. Score 15/100. As of 2026-11-04, from U.S. FDA National Drug Code (NDC) Directory via openFDA.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Free preview: all 12 published fields of this record are shown below. Locked: 499 related FdaNdcDirectoryPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Product | BYT BANGYTONG STYE EYE RELIEF SERUM |
| Generic name | (hippophae rhamnoides seed oil , calendula officinalis flower , persea gratissima- avocado oil liquid) |
| NDC | 87382-028 |
| Labeler | Shenzhen Jindali Technology Co., Ltd |
| Product type | HUMAN OTC DRUG |
| Approval pathway | OTC MONOGRAPH DRUG |
| Application number | 505G(a)(3) |
| Dosage form | LIQUID |
| Route | TOPICAL |
| Active ingredients | PERSEA GRATISSIMA (AVOCADO) OIL .15 g/mL; HIPPOPHAE RHAMNOIDES SEED OIL .05 g/mL; CALENDULA OFFICINALIS FLOWER .01 g/mL |
| Marketing start | 2026-10-22 |
| Package configurations | 1 |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch BYT BANGYTONG STYE EYE RELIEF SERUM
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock BYT BANGYTONG STYE EYE RELIEF SERUM + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL
- Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
- Record date: 2026-10-22
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top FdaNdcDirectoryPulse records (HUMAN OTC DRUG first): Dove (Clinical and Sleep Shield Vanilla Dream Underarm Antip · ZKBB ECZEMA (Allantoin) by Guchutang Biotechnology (Longyan) · ZKBB WART REMOVER (Salicylic acid) by Guchutang Biotechnolog · ZKBB WART REMOVER (Salicylic Acid) by Guchutang Biotechnolog · ARNICA BRUISE (Arnica montana) by Shenzhen Fanyi Era Technol · Browse all by state and category →
LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Wed, 04 Nov 2026 18:12:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: BYT BANGYTONG STYE EYE RELIEF SERUM and 2,418 HUMAN OTC DRUG peers
- HUMAN OTC DRUG FdaNdcDirectoryPulse records like this one: 2,418
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every HUMAN OTC DRUG peer: $483,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
15 / 100 Launch Signal Score
What is the FdaNdcDirectoryPulse record for BYT BANGYTONG STYE EYE RELIEF SERUM?
BYT BANGYTONG STYE EYE RELIEF SERUM by Shenzhen Jindali Technology Co., Ltd: new human otc drug listing (OTC MONOGRAPH DRUG) starting 2026-10-22.
How does BYT BANGYTONG STYE EYE RELIEF SERUM compare to other FdaNdcDirectoryPulse records?
It is fresh: dated 14 days ago, inside the window where early outreach matters most. Its Launch Signal Score of 15/100 is modest; treat it as background rather than a priority.
BYT BANGYTONG STYE EYE RELIEF SERUM vs. top 3 peers
| Organization | Location | Record date | Compare |
|---|---|---|---|
| BYT BANGYTONG STYE EYE RELIEF SERUM | HUMAN OTC DRUG | 2026-10-22 | This record |
| BRYTLY | HUMAN OTC DRUG | 2026-10-16 | Compare BYT BANGYTONG STYE EYE RELIEF SERUM vs BRYTLY → |
| OMEPRAZOLE | HUMAN OTC DRUG | 2026-09-11 | View record → |
| Nicotine Transdermal System step 1 | HUMAN OTC DRUG | 2026-09-01 | View record → |
Related records
FdaNdcDirectoryPulse: Over the counter (OTC) FdaNdcDirectoryPulse: OTC monograph
How to monitor BYT BANGYTONG STYE EYE RELIEF SERUM and peer otc monograph records
Get new FdaNdcDirectoryPulse records like BYT BANGYTONG STYE EYE RELIEF SERUM by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.